Nano-X Imaging Ltd. (NASDAQ:NNOX) Given Average Rating of “Moderate Buy” by Analysts

Nano-X Imaging Ltd. (NASDAQ:NNOX) has earned a consensus rating of “Moderate Buy” from the six brokerages that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, two have given a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $4.3333.

NNOX has been the subject of several research reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Nano-X Imaging in a research note on Wednesday, July 8th. Cantor Fitzgerald restated an “overweight” rating and issued a $5.00 price objective on shares of Nano-X Imaging in a report on Monday, August 17th. Alliance Global Partners cut shares of Nano-X Imaging from a “buy” rating to a “neutral” rating and cut their price objective for the company from $5.00 to $3.00 in a research note on Tuesday, July 7th. Finally, Zacks Research raised shares of Nano-X Imaging from a “strong sell” rating to a “hold” rating in a report on Monday, June 22nd.

Nano-X Imaging Trading Up 1.5%

NNOX opened at $0.88 on Thursday. The stock has a 50-day moving average price of $1.10 and a 200-day moving average price of $1.79. Nano-X Imaging has a 12-month low of $0.73 and a 12-month high of $4.71. The stock has a market capitalization of $68.83 million, a P/E ratio of -0.55 and a beta of 1.26.

Nano-X Imaging (NASDAQ:NNOX) last announced its quarterly earnings data on Thursday, June 25th. The company reported ($0.16) EPS for the quarter. The firm had revenue of $4.31 million for the quarter. Nano-X Imaging had a negative net margin of 716.44% and a negative return on equity of 70.96%. On average, equities research analysts predict that Nano-X Imaging will post -0.6 EPS for the current year.

Insider Buying and Selling at Nano-X Imaging

In other Nano-X Imaging news, CEO Erez Meltzer purchased 36,000 shares of the business’s stock in a transaction on Monday, July 27th. The stock was acquired at an average cost of $0.93 per share, for a total transaction of $33,480.00. Following the completion of the transaction, the chief executive officer directly owned 36,000 shares in the company, valued at approximately $33,480. This represents a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Dan S. Suesskind purchased 50,000 shares of the business’s stock in a transaction on Monday, July 27th. The shares were acquired at an average price of $0.93 per share, with a total value of $46,500.00. Following the completion of the transaction, the director owned 50,000 shares of the company’s stock, valued at approximately $46,500. This trade represents a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders acquired 95,443 shares of company stock valued at $89,706 over the last three months. 7.74% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Nano-X Imaging

Several institutional investors have recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Nano-X Imaging by 8.4% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 35,182 shares of the company’s stock valued at $182,000 after buying an additional 2,724 shares during the period. The Manufacturers Life Insurance Company lifted its stake in Nano-X Imaging by 20.5% in the second quarter. The Manufacturers Life Insurance Company now owns 22,433 shares of the company’s stock worth $116,000 after acquiring an additional 3,818 shares during the period. Russell Investments Group Ltd. lifted its stake in Nano-X Imaging by 62.1% in the third quarter. Russell Investments Group Ltd. now owns 13,787 shares of the company’s stock worth $51,000 after acquiring an additional 5,283 shares during the period. BNP Paribas Financial Markets boosted its holdings in Nano-X Imaging by 64.6% in the third quarter. BNP Paribas Financial Markets now owns 19,743 shares of the company’s stock valued at $73,000 after acquiring an additional 7,749 shares in the last quarter. Finally, Mariner LLC boosted its holdings in Nano-X Imaging by 70.5% in the fourth quarter. Mariner LLC now owns 20,825 shares of the company’s stock valued at $58,000 after acquiring an additional 8,614 shares in the last quarter. 21.49% of the stock is currently owned by hedge funds and other institutional investors.

Nano-X Imaging Company Profile

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.